INFORMATION FOR THE MEDIA
_Galenica and its companies maintain an active and transparent information policy with respect to all stakeholders. Consistency and credibility are two fundamental values which are reflected in factual, comprehensive and objective communication.
_As a listed company on the Swiss Stock Exchange, we are bound to observe the directive on ad hoc publicity. That is why we communicate important and price-sensitive facts via electronic media in a timely manner. You will find all Galenica publications, media releases and media conference documentation, together with further supplementary information about the Group, on our website.
Contact
Galenica Ltd.
Media Relations
Untermattweg 8
CH-3027 Bern
- Phone:
- +41 58 852 85 17
- Fax:
- +41 58 852 85 58
Media releases
FDA assigns PDUFA Date for Injectafer® NDA
15 December 2011
Downloads
Links
- Home
- Media